VIGL
USDVigil Neuroscience Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.440
Kõrge
$2.800
Madal
$2.402
Maht
0.05M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
128.3M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.22M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13
Wedbush analyst Laura Chico maintains Vigil Neuroscience with a Outperform and lowers the price target from $24 to $13.
HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14
HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience with a Buy and lowers the price target from $17 to $14.
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis
Seotud aktsiad
GYRE
Gyre Therapeutics Inc.
HSTM
HealthStream Inc.
SHIM
Shimmick Corporation
DCOMP
Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A
NECB
NorthEast Community Bancorp Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.